Download Citation
Article Source:
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study
Bockstal V,
Shukarev G,
McLean C,
Goldstein N,
Bart S,
et al.
(2022)
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study.
PLOS ONE 17(10): e0274906.
https://doi.org/10.1371/journal.pone.0274906